annb0t
Top 20
ADELAIDE, Australia, Aug. 2, 2022 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce NEXTSTELLIS® (drospirenone and estetrol tablets) has been nominated for the 2022 Prix Galien USA Award for Best Pharmaceutical Agent.
NEXTSTELLIS® is the first and only contraceptive pill containing a new low impact[1] estrogen, estetrol (E4), and a progestin, drospirenone. E4 is a natural estrogen produced by the huma...
>>> Read more: NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
NEXTSTELLIS® is the first and only contraceptive pill containing a new low impact[1] estrogen, estetrol (E4), and a progestin, drospirenone. E4 is a natural estrogen produced by the huma...
>>> Read more: NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
